Quantcast

Hatch Medical Signs Brokerage Agreement With Evexar Medical

August 22, 2008

US-based Hatch Medical, a medical device incubator and technology brokerage firm, has signed an agreement with the UK-based Evexar Medical to broker its collagen-based sealing technology, EndoSeal.

Evexar Medical, in co-operation with University College London, has developed a technology to address endoleaks. The patented Evexar EndoSeal technology effectively seals gaps that can occur between an endograft and an irregular vessel wall, ensuring a secure seal and substantially reducing the possibility of endoleaks, according to Hatch Medical.

Paul Gianneschi, managing principal and founder of Hatch Medical, said: “We are very pleased to be working with Evexar Medical and believe that the EndoSeal technology will provide innumerable benefits and greater procedural options for clinicians, patients and endograft manufacturers by reducing the long-term complications associated with endograft placement.”




comments powered by Disqus